Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer
- 4 May 2018
- journal article
- research article
- Published by Taylor & Francis in Epigenetics
- Vol. 13 (5) , 490-504
Abstract
The accurate diagnosis of endometrial cancer (EC) holds great promise for improving its treatment choice and prognosis prediction. This work aimed to identify diagnostic biomarkers for differentiating EC tumors from tumors in other tissues, as well as prognostic signatures for predicting survival in EC patients. We identified 48 tissue-specific markers using a cohort of genome-wide methylation data from three common gynecological tumors and their corresponding normal tissues. A diagnostic classifier was constructed based on these 48 CpG markers that could predict cancerous versus normal tissue with an overall correct rate of 98.3% in the entire repository. Fifteen CpG markers associated with the overall survival (OS) and development of EC were also identified based on the methylation patterns of the EC samples. A prognostic model that aggregated these prognostic CpG markers was established and shown to have a higher discriminative ability to distinguish EC patients with an elevated risk of mortality than the FIGO staging system and several other clinical prognostic variables. This study presents the utility of DNA methylation in identifying biomarkers for the diagnosis and prognosis of EC and will help improve our understanding of the underlying mechanisms involved in the development of EC.Keywords
Funding Information
- National Natural Science Foundation of China (31670784 and 31370795)
This publication has 41 references indexed in Scilit:
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter EvaluationJNCI: Journal of the National Cancer Institute, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- COHCAP: an integrative genomic pipeline for single-nucleotide resolution DNA methylation analysisNucleic Acids Research, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Endometrial carcinoma: molecular alterations involved in tumor development and progressionOncogene, 2012
- A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studiesThe Lancet, 2012
- Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell linesInternational Journal of Oncology, 2011
- Oxytocin Increases Invasive Properties of Endometrial Cancer Cells Through Phosphatidylinositol 3-Kinase/AKT-Dependent Up-Regulation of Cyclooxygenase-1, -2, and X-Linked Inhibitor of Apoptosis Protein1Biology of Reproduction, 2011
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological FunctionsEndocrine Reviews, 2001